VEGF has been shown to impair leukocyte‐endothelial interactions by reducing the adhesion molecules, ICAM‐1, VCAM‐1, and LFA‐1, in angiogenic vessels and hampering the infiltration of T‐effector cells into tumours.33, 34. Here, VCAM1 is linked to neoplasm.